Zobrazeno 1 - 10
of 127
pro vyhledávání: '"NURİYE ÖZDEMİR"'
Autor:
Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, Tahir Yerlikaya, Engin Hendem, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Şahin, Teoman Şakalar, Nilay Şengül Samancı, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algın, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Berna Öksüzoğlu, Aydın Yavuz, Osman Yüksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Özdemir
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Neoadjuvant treatment is the standard treatment in locally advanced ESCC. However, the optimal chemotherapy regimen is not known. Method This is a retrospective observational cohort study conducted with propensity score matching.
Externí odkaz:
https://doaj.org/article/0c2407cd5a0448378847928577fc42af
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Berna Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Özdemir
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predic
Externí odkaz:
https://doaj.org/article/064c7efbc4eb4b068e1b246c055dc512
Autor:
OSMAN SÜTCÜOĞLU, ZEYNEP SEZGİ ERDAL, ORHUN AKDOĞAN, EMRAH ÇELTİKÇİ, NURİYE ÖZDEMİR, AHMET ÖZET, MURAT UÇAR, OZAN YAZICI
Publikováno v:
Turkish Journal of Medical Sciences. 53:420-431
Autor:
Osman SÜTCÜOĞLU, Mehmet Arda İNAN, Aytuğ ÜNER, Gözde SAVAŞ, Hüseyin BORA, Ahmet ÖZET, Nazan GÜNEL, Nalan AKYÜREK, Ozan YAZICI, Nuriye ÖZDEMİR
Publikováno v:
Journal of Oncological Sciences. 9:23-32
Publikováno v:
Indian Journal of Gynecologic Oncology. 21
Autor:
Tuğba Başoğlu, Abdullah Sakin, Cihan Erol, Ercan Özden, Devrim Çabuk, Ebru Çılbır, Deniz Tataroğlu Özyükseler, Murat Ayhan, Mehmet Ali Şendur, Mutlu Dogan, Berna Öksüzoğlu, Melek Karakurt Eryılmaz, Özlem Er, Elif Şenocak Taşçı, Neslihan Özyurt, Özgecan Dülgar, Miraç Özen, İlhan Hacıbekiroğlu, İrem Öner, Esma Türkmen Bekmez, Hasan Çağrı Yıldırım, Şuayib Yalçın, Semra Paydaş, Emre Yekedüz, Asude Aksoy, Melike Özçelik, Abdilkerim Oyman, Elvina Almuradova, Bülent Karabulut, Nazan Demir, Murat Dinçer, Nuriye Özdemir, Dilek Erdem, Naziye Ak, Ali İnal, Derya Kıvrak Salim, Gülhan İpek Deniz, Teoman Şakalar, Ahmet Gülmez, Turgut Kaçan, Özlem Özdemir, Özkan Alan, Çağlar Ünal, Yusuf Karakaş, Serdar Turhal, Perran Fulden Yumuk
Publikováno v:
Journal of Chemotherapy. 35:142-149
Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare the efficacy and toxicity
Autor:
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi, Yusuf Günaydin, Serkan Menekşe, Berna Öksüzoğlu, Asude Aksoy, Bülent Erdoğan, M. Bekir Hacıoglu, Erkan Arpaci, Alper Sevinç, Mehmet Atilla Uysal, Sinem İliaz
Publikováno v:
Balkan Medical Journal, Vol 33, Iss 5, Pp 517-524 (2016)
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are treated similarly. Serous/cle
Externí odkaz:
https://doaj.org/article/a941accd41ad4cb09b80b59a161a3f2c
Autor:
Mutlu HIZAL, Mehmet Ali Nahit ŞENDUR, Burak BİLGİN, Ebru KARCI GÜNER, Muhammed Bülent AKINCI, Yakup ERGÜN, Ece ESİN, Elif Berna KÖKSOY, Ahmet SEZER, Nuriye ÖZDEMİR, Berna ÖKSÜZOĞLU, Bülent YALÇIN, Güngör UTKAN, Yüksel ÜRÜN
Publikováno v:
Journal of Oncological Sciences. 8:69-75
ABS TRACT Objective: Pancreatic cancer is one of the leading causes of cancer-related death. Despite the introduction of new therapeutic agents, survival rates remain low. Furthermore, few trials have evaluated the options for second-line therapy and
Autor:
Görkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, Deniz Can Güven, Altan Kavuncuoğlu, Nuriye Özdemir, Ahmet Özet, Sercan Aksoy, Yeşim Gaye Güler Tezel, Nalan Akyürek, Ozan Yazıcı
Publikováno v:
Strahlentherapie und Onkologie.
Publikováno v:
Journal of Gastrointestinal Cancer.